Home healthcare Market worth US$159.6 Billion By 2014

Home Healthcare Brief

Home Healthcare is nothing but Healthcare service provided at home by licensed healthcare professionals who provide medical care needs or by professional caregivers who provide daily care to help to ensure the activities of daily living are met. Home Healthcare helps adults and senior citizen to recover after hospital treatment at their home. These Home Care service includes short-term nursing, rehabilitative, therapeutic, and assistive home health care. These services provided by registered nurses, physical therapists, occupational therapists, speech language pathologists, home health aides, medical social workers and some times by Doctors.

 Home Healthcare includes

• Any diagnostic, therapeutic, or social support service provided in the home 
• Health care providers who provide home care
• Home diagnostics
• Home equipment
• A variety of services designed to provide care for patients in their homes 

These are Home Healthcare Providers

• Physicians, nurse practitioners, physician assistants
• Physical therapists, occupational therapists, speech therapists
• Nurses
• Social workers
• Home health aids
• Dentists, podiatrists, psychologists, dietitians, optometrists, and pharmacists 

Equipment and Diagnostics Provided During Home-care 

• Lab work, x-ray, ultrasound, EKG, holter monitoring, other diagnostics that can be done in the home.

• Beds, wheelchairs, lifts, commodes, infusion therapy, and other assistive devices used in the home.

Home Health Market will increase as

• Patients are discharged from the hospital earlier.
• More conditions are treated at home.
• Treatments for chronic conditions become even more complex.

Current Home Healthcare Market

Currently Home Healthcare is one of the highest growth achiever in Healthcare Segment. Specially in United States .The most important healthcare trend witnessed recently is the focus shift of patients from hospitals to home healthcare. The move from treatment to proactive monitoring is also opening up new opportunities for the home healthcare market. Patients prefer home healthcare to hospitals mainly for the convenience and cost-effectiveness it offers. Third-party home healthcare is also witnessing huge demand due to better treatment quality ensured by trained medical professionals.

Future of Home Healthcare According to Report

The home healthcare market generates approximately 70% of revenues from the people aged 65 years and above; mainly because of the declining ‘elderly support ratio’, or the ratio of the number of people caring for the elderly, to the number of older people above 65 years. This factor highlights the growth potential of the market for third-party care in the coming years. The entire home healthcare market covered under the report is estimated to be approximately $159.6 billion and is expected to grow by 8.2% to reach $237.6 billion by 2014. Home healthcare service market is estimated to constitute $143.1 billion in 2009, which is about 90% of the entire market.

The major factors driving the growth of the home healthcare market are

•     Declining elderly support ratio
•     Patient preference for portability, automation and customization
•     Physicians and hospitals prescribing home care to the patients to reduce huge patient inflow
•     Rise in number of vehicle accidents and sports injuries 

Major opportunities for the home healthcare market

•     Focus shift from treatment to proactive monitoring
•     Rising demand of third-party care 

The market for home healthcare services is estimated to reach $207 billion by 2014. Home visits and nursing services constitute 72% of the entire market. Most of the growth potential lies in the field of home telemedicine services, the market for which is forecasted to grow at a CAGR of 32.3% from 2009 to 2014. Diabetes devices alone constitute about 46% of the entire home healthcare equipment market, while the market for home therapeutic equipment is the fastest-growing segment with a CAGR of 19.4%.

        For More Information About Healthcare and Report : 

                                            Click Here 

U.S. Electronic Medical Records (EMR) Market to reach $6 Billion mark by 2015

Electronic medical record (EMR) are a vast improvement over paper records. They allow more than one person to use a patient’s chart, are usually better organized than paper records, eliminate illegible handwriting, and allow storage of more information. An electronic medical record  is a digital version of a paper chart that contains all of a patient’s medical history from one practice. An EMR is mostly used by providers for diagnosis and treatment.

                                                    The information stored in EMRs is not easily shared with providers outside of a practice. A patient’s record might even have to be printed out and delivered by mail to specialists and other members of the care team. EMRs are one of the best ways to boost patient safety, manage chronic illnesses, and improve the efficiency of a practice. They also offer an excellent way to prescribe medication.

Benefits of Electronic Medical Records:

Electronic Medical Record is more beneficial than paper records because it allows providers to:

• Track data over time
• Identify patients who are due for preventive visits and screenings
• Monitor how patients measure up to certain parameters, such as vaccinations and blood pressure readings
• Improve overall quality of care in a practice

Future of Electronic Medical Record :

• The long journey to the future success of healthcare starts with "electronic medical records" (EMR), a software-based solution that provides for the digital computerization, recording, and maintenance of patient and medical practice information. The EMR solution addresses the need to establish quality in patient care and viability in medical practice. It seeks to ensure the rendition of accurate, efficient, organized, and collaborative exercise of practice competencies for predictable and favorable patient outcomes.

  According to Our U.S. EMR Market Research Report :

• The rising demand for healthcare cost containment and need to improve quality of healthcare service are driving the growth of the U.S. EMR market. In addition to this, the federal incentives of $20 billion for healthcare providers to achieve “meaningful use” of EMR solutions by 2015 are expected to drive the EMR market during the forecasted period. The U.S. EMR market is expected to grow from $2,177 million in 2009 to $6,054 million in 2015, at a CAGR of 18.1% from 2010 to 2015.

Scope of Report :

• The report evaluates the U.S. EMR market with respect to its sub-segments on the basis of end users, components, and applications.

• Each section provides market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report also provides market tables for covering the sub-segments and micro-markets. In addition, the report also provides more than 20 company profiles covering all the sub-segments.

                                                            FRAMEWORK OF integrated EMR SYSTEM

   Image Source : Markets and Markets

At present, the market players are focusing on development of interoperable EMR solutions. Many companies have opted the route of agreements and partnerships to pull technical expertise and achieve their objective. Lowering the cost of EMR implementation is another burning issue within the industry that has driven growth of web-based EMR solutions within the industry. Though the client-server based EMRs formed approximately 76% of the EMR software market in 2009, web-based EMRs are gaining greater popularity within the smaller healthcare practices and expected to gain higher market share by 2015.

Industry players with the most significant developments include Allscripts, Cerner, McKesson, EMIS, and NextGen. They are undergoing consolidation to achieve marketing and distribution synergy and develop an interoperable EMR solution.

  For Further Inquiry About this Report Click Here

Global Medical Bionic Implants Market worth $17.82 Billion by 2017

Meaning of Bionics is bionical creativity engineering means the replacement or enhancement of organs or other body parts by mechanical versions. Bionic implants differ from mere prostheses by mimicking the original function very closely, or even surpassing it. Bionics Cover different body part separately and it includes many separate Domain Expertise vision bionics, Ear Bionics, orthopedic Bionics, Heart Bionics, Neutral/Brain Bionics.

Examples of Bionic Devices:

• Artificial Heart

• Artificial Muscle

• Cochlear Implant

• Bioelectrodes

• Mechanoactive Cartilage

A medical bionics industry will bring:

• Improved patient health

• Skills development

• Job creation

• Long term export earnings

• New opportunities for innovative technology solutions

Our Bionic Market Research Report Says:

Report Says, The global artificial organs market has been segmented as vision bionics, ear bionics, orthopedic bionics, heart bionics, and neural/brain bionics. Heart bionics accounts for the largest share in this market, primarily due to a large global population with heart diseases. Rising healthcare expenditure and emergence of new healthcare facilities in emerging economies provides growth opportunities for the medical bionic implants market. The market for certain bionic devices such as exoskeletons, bionic orthopedics, and the bionic eye are skewed in favor of certain regions because of stronger research in these regions as compared to others. In this report, we are also focusing on bionic devices in pipeline, which include wearable artificial kidney, bio-lung, and artificial pancreas.

According to the Report, Expert Interviews and MnM Analysis The medical bionic implants market is a potentially growing one with a global market of $12.67 million in 2012. It is expected to grow at a CAGR of 7.1% to reach $17.82 billion in 2017.

The global artificial organs market has been segmented as vision bionics, ear bionics, orthopedic bionics, heart bionics, and neural/brain bionics. Heart bionics accounts for the largest share in this market, primarily due to a large global population with heart diseases. Rising healthcare expenditure and emergence of new healthcare facilities in emerging economies provides growth opportunities for the medical bionic implants market. 

           GLOBAL MEDICAL BIONICS IMPLANT /ARTIFICIAL ORGANS MARKET SHARE, BY PRODUCTS, 2017

                                                    Image Source : MarketsandMarkets

The key players in this market are Orthofix International N.V. (The Netherlands), Biomet, Inc. (U.S.), Medtronic, Inc. (U.S.), Cochlear Ltd. (Australia), Second Sight Medical Products, Inc. (U.S.), Ossur (Iceland), Ekso Bionics (U.S.), and St. Jude Medical, Inc. (U.S.).

Scope of The Report :

This research report categorizes the global medical bionic implants market on the basis of products, technologies, and type of fixation. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography (North America, Europe, Asia-Pacific, and Rest of the World) to provide in-depth information on the global scenario.

Global Medical Bionics Market, By Products:

• Vision Bionics 

               Bionic Eye    

       

•   Ear Bionics     

               Cochlear Implant 

               Bone Anchored Hearing Aid (Baha)      

• Orthopedic Bionics    

                Bionic Limb     

                Bionic Hand        

                Bionic Leg  

                Bionic Finger

                Exoskeleton       

                Electrical Bone Growth Stimulators      

• Heart Bionics 

                Pacemaker

                Total Artificial Heart      

                Ventricular Assist Device

                Artificial Heart Valves    

• Neural /Brain Bionics

                Deep Brain Stimulator   

                Vagus Nerve Stimulator 

                Spinal Cord Stimulator   

Global Medical Bionics Market, By Technology:

• Mechanical
• Electronic

Global Medical Bionics Market, By Method of Fixation:

• Implantable
• Externally Worn

Medical Bionics Market, By Geography:

• North America
• Europe
• Asia-Pacific
• RoW (Rest of World)

     For Further Inquiry About this Report Click Here

Global DNA and Gene Chip Market 2010 – 2015

A DNA and Gene Chip(microarray) also known as Biochip is a collection of microscopic DNA spots attached to a solid surface. DNA microarrays use to measure the expression levels of large numbers of genes simultaneously or to genotype multiple regions of a genome. Two types of DNA microarrays Available, Which are cDNA (complementary DNA), and oDNA (oligonucleotide DNA) with oDNA dominating the market with a share of almost 98%. The global DNA and gene chip (Microarray) market offers tremendous growth potential and has witnessed the entry of a number of players striving for a share in this market.

According to Report, The global DNA & gene chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. Affymetrix, Inc. dominate this market mainly due to high density of their chips, sizeable number of patents, first-to-market presence, and many research and commercial partnerships. The other players include Illumina, Inc., Agilent Technologies, Inc., Roche Nimblegen, Sequenom Inc., Applied Microarrays, and others.

                                                             Global DNA & Gene Chip Market Reports Consists  

Image Source : MarketsandMarkets

Report says, North America who dominated the global DNA and gene chip market with maximum share in 2010.However, this share is likely to drop down in 2015 as the market has already reached maturity. Expected growth comes from Asian economies, especially China, India, South Korea, and Singapore. Where funding of government and investment in biotechnology play major roles. China and India being the most populous countries would provide the largest base for clinical trials and drug discovery and thus will positively impact the DNA microarray market.

Scope of the report:

This research report categorizes the global DNA & gene chip (microarray) market on the basis of applications, types, and geography; forecasting revenues, and analyzing trends in each of the following submarkets:

On the basis of applications:

• Gene expression, cancer diagnostics & treatments, drug discovery, genetics (DNA sequencing by hybridization, reverse genetics, functional genomics, and genomic mismatch scanning, gene mapping, diagnosis), SNP analysis, screening & monitoring of patient data during clinical trials, proteomics, toxicogenomics, microbial genotyping, agricultural biology, and environmental control

On the basis of types:

• Oligonucleotide DNA microarrays (oDNA) and complementary DNA microarrays (cDNA)

On the basis of geography:

• North America (U.S., Canada)
• Europe (Germany, France, Italy, Spain, UK)
• Asia (India, China, Japan, South Korea), and 
• Rest of the World

Each section provides market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report also provides market tables for covering the sub-segments. In addition, the report provides more than 30 company profiles covering all the sub-segments.

For Browsing, Buying and Sample request of This Report Available on Below Link, By clicking below you Redirected to report : 

                        Global DNA & Gene Chip Market Report